Results 141 to 150 of about 6,078 (162)

Characterization of swallowing in older adults with dementia. [PDF]

Codas
Santos BS, Lira JO, Mangilli LD.
europepmc   +1 more source

Comunicaciones LX Reunión Anual SENFC Barcelona, 2 a 4 de octubre de 2024. [PDF]

Rev Neurol
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

Lancet, The, 2022
Craig M Mcdonald, Eduardo Marbán, Suzanne Hendrix   +2 more
exaly  

Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study

Lancet, The, 2016
Richard S Finkel, Claudia A Chiriboga, John W Day   +2 more
exaly  

Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study

Lancet, The, 2018
Craig M Mcdonald, Paula R Clemens, Heather Gordish-Dressman   +2 more
exaly  

Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study

Lancet, The, 2011
Sebahattin Cirak, V Arechavala-Gomeza, Michela Guglieri   +2 more
exaly  

Efficacy of idebenone on respiratory function in patients with Duchenne muscular dystrophy not using glucocorticoids (DELOS): a double-blind randomised placebo-controlled phase 3 trial

Lancet, The, 2015
Thomas Voit, Janbernd Kirschner, Richard S Finkel   +2 more
exaly  

Spinal muscular atrophy

Lancet, The, 2008
Mitchell R Lunn
exaly  

Muscular dystrophies

Lancet, The, 2019
Eugenio Mercuri, Francesco Muntoni
exaly  

Molecular mechanisms of muscular dystrophies: old and new players

Nature Reviews Molecular Cell Biology, 2006
Kristen J Nowak
exaly